Cancer Chemotherapy and Pharmacology

, Volume 54, Issue 4, pp 315–321 | Cite as

Ascorbate modulation of H2O2 and camptothecin-induced cell death in Jurkat cells

  • Alain-Théophile Sané
  • André M. Cantin
  • Benoit Paquette
  • J. Richard Wagner
Original Article


The effect of ascorbate on cell death was examined in Jurkat cells (human T-cell leukemia) by incubation with dehydroascorbate (DHA), which is rapidly taken up by cells and efficiently reduced to ascorbate. Apoptosis was evaluated by caspase-3 activity in cell extracts and flow cytometry of annexin V-labeled cells. In parallel, necrosis was estimated by the release of lactate dehydrogenase. Minor effects on cell death were observed when Jurkat cells were incubated with either DHA alone (100–1,000 μM) or a single dose of 10 μM H2O2. However, pre-incubation with DHA followed by exposure to H2O2 clearly stimulated both apoptosis and necrosis. In complete contrast, pre-incubation of cells with DHA significantly inhibited apoptosis, but did not affect necrosis, induced by the topoisomerase I inhibitor camptothecin. Our results indicate that intracellular ascorbate can modulate cell death in a manner which depends upon the nature of the apoptotic stimulus, which in turn has critical implications regarding the mechanism and potential application of ascorbate in cancer therapy.


Dehydroascorbate Reactive oxygen species Topoisomerase inhibitors 



20-S-camptothecin lactone




Lactate dehydrogenase










  1. 1.
    Agus DB, Vera JC, Golde DW (1999) Stromal cell oxidation: a mechanism by which tumors obtain vitamin C. Cancer Res 59:4555–4558PubMedGoogle Scholar
  2. 2.
    Antunes F, Cadenas E (2001) Cellular titration of apoptosis with steady state concentrations of H2O2: submicromolar levels of H2O2 induce apoptosis through fenton chemistry independent of the cellular thiol state. Free Radic Biol Med 30:1008–1018CrossRefPubMedGoogle Scholar
  3. 3.
    Asano K, Satoh K, Hosaka M, Arakawa H, Inagaki M, Hisamitsu T, Maeda M, Kochi M, Sakagami H (1999) Production of hydrogen peroxide in cancerous tissue by intravenous administration of sodium 5,6-benzylidene-l-ascorbate. Anticancer Res 19:229–236PubMedGoogle Scholar
  4. 4.
    Bachleitner-Hofmann T, Gisslinger B, Grumbeck E, Gisslinger H (2001) Arsenic trioxide and ascorbic acid: synergy with potential implications for the treatment of acute myeloid leukaemia? Br J Haematol 112:783–786CrossRefPubMedGoogle Scholar
  5. 5.
    Barbouti A, Doulias PT, Nousis L, Tenopoulou M, Galaris D (2002) DNA damage and apoptosis in hydrogen peroxide-exposed Jurkat cells: bolus addition versus continuous generation of H2O2. Free Radic Biol Med 33:691–702CrossRefPubMedGoogle Scholar
  6. 6.
    Bijur GN, Briggs B, Hitchcock CL, Williams MV (1999) Ascorbic acid-dehydroascorbate induces cell cycle arrest at G2/M DNA damage checkpoint during oxidative stress. Environ Mol Mutagen 33:144–152CrossRefPubMedGoogle Scholar
  7. 7.
    Cameron E, Campbell A (1974) The orthomolecular treatment of cancer. II. Clinical trial of high-dose ascorbic acid supplements in advanced human cancer. Chem Biol Interact 9:285–315CrossRefPubMedGoogle Scholar
  8. 8.
    Casciari JJ, Riordan NH, Schmidt TL, Meng XL, Jackson JA, Riordan HD (2001) Cytotoxicity of ascorbate, lipoic acid, and other antioxidants in hollow fibre in vitro tumours. Br J Cancer 84:1544–1550CrossRefPubMedGoogle Scholar
  9. 9.
    Chandra J, Samali A, Orrenius S (2000) Triggering and modulation of apoptosis by oxidative stress. Free Radic Biol Med 29:323–333CrossRefPubMedGoogle Scholar
  10. 10.
    Chau YP, Shiah SG, Don MJ, Kuo ML (1998) Involvement of hydrogen peroxide in topoisomerase inhibitor beta-lapachone-induced apoptosis and differentiation in human leukemia cells. Free Radic Biol Med 24:660–670CrossRefPubMedGoogle Scholar
  11. 11.
    Clement MV, Ramalingam J, Long LH, Halliwell B (2001) The in vitro cytotoxicity of ascorbate depends on the culture medium used to perform the assay and involves hydrogen peroxide. Antiox Red Sign 3:157–163CrossRefGoogle Scholar
  12. 12.
    Crott JW, Fenech M (1999) Effect of vitamin C supplementation on chromosome damage, apoptosis and necrosis ex vivo. Carcinogenesis 20:1035–1041CrossRefPubMedGoogle Scholar
  13. 13.
    Guaiquil VH, Farber CM, Golde DW, Vera JC (1997) Efficient transport and accumulation of vitamin C in HL-60 cells depleted of glutathione. J Biol Chem 272:9915–9921CrossRefPubMedGoogle Scholar
  14. 14.
    Guaiquil VH, Vera JC, Golde DW (2001) Mechanism of vitamin C inhibition of cell death induced by oxidative stress in glutathione-depleted HL-60 cells. J Biol Chem 276:40955–40961CrossRefPubMedGoogle Scholar
  15. 15.
    Hampton MB, Orrenius S (1997) Dual regulation of caspase activity by hydrogen peroxide: implications for apoptosis. FEBS Lett 414:552–556CrossRefPubMedGoogle Scholar
  16. 16.
    Hoffer LJ (2001) Proof versus plausibility: rules of engagement for the struggle to evaluate alternative cancer therapies. Can Med Assoc J 164:351–353Google Scholar
  17. 17.
    Hussein MA (2001) Arsenic trioxide—a new immunomodulatory agent in the management of multiple myeloma. Med Oncol 18:239–242CrossRefPubMedGoogle Scholar
  18. 18.
    Kang JS, Cho DH, Kim YI, Hahm E, Yang YH, Kim D, Hur D, Park H, Bang S, Hwang YI, Lee WJ (2003) l-ascorbic acid (vitamin C) induces the apoptosis of B16 murine melanoma cells via a caspase-8-independent pathway. Cancer Immunol Immunother 52:693–698CrossRefPubMedGoogle Scholar
  19. 19.
    Kaufmann SH (1998) Cell death induced by topoisomerase-targeted drugs: more questions than answers. Biochim Biophys Acta 1400:195–211CrossRefPubMedGoogle Scholar
  20. 20.
    Koopman G, Reutelingsperger CP, Kuijten GA, Keehnen RM, Pals ST, van Oers MH (1994) Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood 84:1415–1420PubMedGoogle Scholar
  21. 21.
    Lee YJ, Shacter E (2000) Hydrogen peroxide inhibits activation, not activity, of cellular caspase-3 in vivo. Free Radic Biol Med 29:684–692CrossRefPubMedGoogle Scholar
  22. 22.
    Lee SH, Yoon YC, Jang YY, Song JH, Han ES, Lee CS (2001) Effect of iron and ascorbate on cyclosporine-induced oxidative damage of kidney mitochondria and microsomes. Pharmacol Res 43:161–171CrossRefPubMedGoogle Scholar
  23. 23.
    Lenton KJ, Therriault H, Fulop T, Payette H, Wagner JR (1999) Glutathione and ascorbate are negatively correlated with oxidative DNA damage in human lymphocytes. Carcinogenesis 20:607–613PubMedGoogle Scholar
  24. 24.
    Mizutani H, Tada-Oikawa S, Hiraku Y, Oikawa S, Kojima M, Kawanishi S (2002) Mechanism of apoptosis induced by a new topoisomerase inhibitor through the generation of hydrogen peroxide. J Biol Chem 277:30684–30689CrossRefPubMedGoogle Scholar
  25. 25.
    Padayatty SJ, Levine M (2001) New insights into the physiology and pharmacology of vitamin C. Can Med Assoc J 164:353–355Google Scholar
  26. 26.
    Puskas F, Gergely P, Banki K, Perl A (2000) Stimulation of the pentose phosphate pathway and glutathione levels by dehydroascorbate, the oxidized form of vitamin C. Fed Am Soc Exp Biol J 14:1352–1361CrossRefGoogle Scholar
  27. 27.
    Ricci JE, Gottlieb RA, Green DR (2003) Caspase-mediated loss of mitochondrial function and generation of reactive oxygen species during apoptosis. J Cell Biol 160:65–75CrossRefPubMedGoogle Scholar
  28. 28.
    Rose RC, Bode AM (1995) Analysis of water-soluble antioxidants by high-pressure liquid chromatography. Biochem J 306:101–105PubMedGoogle Scholar
  29. 29.
    Sakagami H, Satoh K (1997) Modulating factors of radical intensity and cytotoxic activity of ascorbate. Anticancer Res 17:3513–3520PubMedGoogle Scholar
  30. 30.
    Sakagami H, Satoh K, Hakeda Y, Kumegawa M (2000) Apoptosis-inducing activity of vitamin C and vitamin K. Cell Mol Biol 46:129–143Google Scholar
  31. 31.
    Sane AT, Bertrand R (1998) Distinct steps in DNA fragmentation pathway during camptothecin-induced apoptosis involved caspase-, benzyloxycarbonyl- and N-tosyl-l-phenylalanylchloromethyl ketone-sensitive activities. Cancer Res 58:3066–3072PubMedGoogle Scholar
  32. 32.
    Schraufstatter IU, Hinshaw DB, Hyslop PA, Spragg RG, Cochrane CG (1985) Glutathione cycle activity and pyridine nucleotide levels in oxidant-induced injury of cells. J Clin Invest 76:1131–1139PubMedGoogle Scholar
  33. 33.
    Schraufstatter IU, Hyslop PA, Hinshaw DB, Spragg RG, Sklar LA, Cochrane CG (1986) Hydrogen peroxide-induced injury of cells and its prevention by inhibitors of poly(ADP-ribose) polymerase. Proc Natl Acad Sci USA 83:4908–4912PubMedGoogle Scholar
  34. 34.
    Shang F, Lu M, Dudek E, Reddan J, Taylor A (2003) Vitamin C and vitamin E restore the resistance of GSH-depleted lens cells to H2O2. Free Radic Biol Med 34:521–530CrossRefPubMedGoogle Scholar
  35. 35.
    Shiah SG, Chuang SE, Chau YP, Shen SC, Kuo ML (1999) Activation of c-Jun NH2-terminal kinase and subsequent CPP32/Yama during topoisomerase inhibitor beta-lapachone induced apoptosis through an oxidation-dependent pathway. Cancer Res 59:391–398PubMedGoogle Scholar
  36. 36.
    Song JH, Shin SH, Wang W, Ross GM (2001) Involvement of oxidative stress in ascorbate-induced proapoptotic death of PC12 cells. Exp Neurol 169:425–437CrossRefPubMedGoogle Scholar
  37. 37.
    Spielholz C, Golde DW, Houghton AN, Nualart F, Vera JC (1997) Increased facilitated transport of dehydroascorbic acid without changes in sodium-dependent ascorbate transport in human melanoma cells. Cancer Res 57:2529–2537PubMedGoogle Scholar
  38. 38.
    Szatrowski TP, Nathan CF (1991) Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res 51:794–798PubMedGoogle Scholar
  39. 39.
    Taper HS, de Gerlache J, Lans M, Roberfroid M (1987) Non-toxic potentiation of cancer chemotherapy by combined C and K3 vitamin pre-treatment. Int J Cancer 40:575–579PubMedGoogle Scholar
  40. 40.
    Verrax J, Cadrobbi J, Delvaux M, Jamison JM, Gilloteaux J, Summers JL, Taper HS, Calderon PB (2003) The association of vitamins C and K3 kills cancer cells mainly by autoschizis, a novel form of cell death. Basis for their potential use as coadjuvants in anticancer therapy. Eur J Med Chem 38:451–457CrossRefPubMedGoogle Scholar
  41. 41.
    Younes M, Lechago LV, Somoano JR, Mosharaf M, Lechago J (1996) Wide expression of the human erythrocyte glucose transporter GLUT1 in human cancers. Cancer Res 56:1164–1167PubMedGoogle Scholar
  42. 42.
    Younes M, Juarez D, Lechago LV, Lerner SP (2001) GLUT 1 expression in transitional cell carcinoma of the urinary bladder is associated with poor patient survival. Anticancer Res 21:575–578PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2004

Authors and Affiliations

  • Alain-Théophile Sané
    • 1
  • André M. Cantin
    • 2
  • Benoit Paquette
    • 3
  • J. Richard Wagner
    • 1
    • 3
  1. 1.Centre de recherche sur le vieillissementInstitut Universitaire de Gériatrie de SherbrookeSherbrookeCanada
  2. 2.Unité de recherche pulmonaireCentre Hospitalier Universitaire de SherbrookeSherbrookeCanada
  3. 3.Département de médecine nucléaire et radiobiologie, Faculté de MédecineUniversité de SherbrookeSherbrookeCanada

Personalised recommendations